ArticlesUpstream July 28, 2023 Xcellerex™ X-platform bioreactor live virtual demo We designed Xcellerex™ X-platform bioreactors to meet your process needs today and in the future. admin-element
ArticlesUpstream June 29, 2023 Future-proof your AAV process with a complete producer cell line – just induce and grow Stable producer cell lines helped to make mAb therapies the powerhouses they are today. admin-element
ArticlesUpstream June 29, 2023 Better bioprocess scaleup with Bioreactor Scaler Pro Are you still using the manual input, trial-and-error method when scaling your cell culture process... admin-element
ArticlesUpstream May 19, 2023 How to develop a scalable rAAV process Adeno-associated virus (AAV) is the most common vector for gene therapy, yet there’s much room… admin-element
ArticlesUpstream March 24, 2023 Quantitative assessment of desirability of platform cell culture media In this study, we compare platform cell culture media with clone – specific media and… admin-element
ArticlesUpstream March 10, 2023 An innovative approach to manufacturing custom CDM with precision accuracy We developed an innovative approach for controlling trace impurities in cell culture media with... admin-element
Q&AUpstream March 6, 2023 Optimizing your Cell Culture Process to Improve Productivity In this video, Mary Szorik and Alicia Elwood at Cytiva, discuss the rationale for cell… admin-element
ArticlesUpstream January 12, 2023 rAAV Production Using HEK293 Cell Line and Transfection Medium Improving the performance of a scalable AAV process in Xcellerex™ XDR-10 and XDR-200 bioreactor... admin-element
ArticlesUpstream October 21, 2021 Cell Culture Media Selection Guide for Your Lab Wall Doing cell culture and upstream process development on antibodies, vaccines, or viruses? admin-element
ArticlesDownstreamUpstream September 9, 2021 Antibody Production Workflow Antibody-based therapies have evolved beyond monoclonal antibodies (mAbs) to include bispecific... admin-element